For the Inventor, By the Inventor

Enter assignee name

Oncoarendi Therapeutics S.a.

USPTO Granted Patents = 8

EPO Patents = 4

Trademarks = 1

Forward Citations = 18

Loading Chart...

Loading Chart...

30 inventors (with patents filed for the assignee):

Adam A Golebiowski (8 out of 14 patents)

Jacek P Olczak (8 out of 12 patents)

Bartlomiej Borek (7 out of 8 patents)

4. Roman Blaszczyk (5 out of 5 patents)

5. Anna Gzik (4 out of 5 patents)

6. Julita Nowicka (4 out of 5 patents)

7. Marek Dziegielewski (4 out of 4 patents)

8. Karol Jedrzejczak (4 out of 4 patents)

9. Joanna Brzezinska (3 out of 3 patents)

10. Krzysztof Matyszewski (3 out of 7 patents)

11. Marzena Mazur (3 out of 7 patents)

12. Robert Koralewski (3 out of 7 patents)

13. Sylwia Olejniczak (3 out of 8 patents)

14. Wojciech J Czestkowski (3 out of 6 patents)

15. Agnieszka Bartoszewicz (3 out of 5 patents)

8 patents: Sort by Forward Citations

1. 12053451 - Arginase inhibitors and their therapeutic applications (2024-08-06),

2. 10912755 - Arginase inhibitors and their therapeutic applications (2021-02-09),

3. 10851099 - Dipeptide piperidine derivatives (2020-12-01),

4. 10538508 - Substituted amino triazoles useful as human chitinase inhibitors (2020-01-21),

5. 10391077 - Arginase inhibitors and their therapeutic applications (2019-08-27),

6. 10329310 - Arginase inhibitors and their therapeutic applications (2019-06-25),

7. 10208020 - Substituted amino triazoles useful as human chitinase inhibitors (2019-02-19),

8. 9944624 - Substituted amino triazoles useful as human chitinase inhibitors (2018-04-17),

Oncoarendi Therapeutics S.a. is a biopharmaceutical company focused on developing novel oncology therapies targeting specific molecular pathways involved in tumor growth and progression. The company's innovative approach aims to improve outcomes for cancer patients by addressing the underlying mechanisms driving cancer proliferation. With a pipeline of promising drug candidates at various stages of development, Oncoarendi Therapeutics is dedicated to advancing precision medicine in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

8 Patents

#13 in Warsaw

#42 in Poland

Oncoarendi Therapeutics S.a.

Forward Citations = 18

30 inventors:

Adam A Golebiowski (8 out of 14 patents)

Jacek P Olczak (8 out of 12 patents)

Bartlomiej Borek (7 out of 8 patents)

4. Roman Blaszczyk (5 out of 5 patents)

5. Anna Gzik (4 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…